Nathalie Barget

2.2k total citations
26 papers, 881 citations indexed

About

Nathalie Barget is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Nathalie Barget has authored 26 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 14 papers in Hepatology and 6 papers in Immunology. Recurrent topics in Nathalie Barget's work include Liver Disease Diagnosis and Treatment (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Hepatitis C virus research (6 papers). Nathalie Barget is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Hepatitis C virus research (6 papers). Nathalie Barget collaborates with scholars based in France, United States and United Kingdom. Nathalie Barget's co-authors include Michel Beaugrand, Nathalie Ganne‐Carrié, Marianne Ziol, G. Nkontchou, Jean–Claude Trinchet, Michael P. Manns, Lars A. Ormandy, Jordi Bruix, Alejandro Forner and Tim F. Greten and has published in prestigious journals such as Gastroenterology, Hepatology and Cancer Research.

In The Last Decade

Nathalie Barget

26 papers receiving 862 citations

Peers

Countries citing papers authored by Nathalie Barget

Since Specialization

Citations

This map shows the geographic impact of Nathalie Barget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Barget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Barget more than expected).

Fields of papers citing papers by Nathalie Barget

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathalie Barget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Barget. The network helps show where Nathalie Barget may publish in the future.

Co-authorship network of co-authors of Nathalie Barget

This figure shows the co-authorship network connecting the top 25 collaborators of Nathalie Barget. A scholar is included among the top collaborators of Nathalie Barget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalie Barget. Nathalie Barget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma 2025 ·JHEP Reports ·Lorraine Blaise, Marianne Ziol, Claudia Campani, Nathalie Ganne‐Carrié, Pierre Nahon, G. Nkontchou, Jessica Zucman‐Rossi, (unknown), Nathalie Barget, (unknown), (unknown), (unknown), Véronique Grando, Lorenzo Pescatori, Olivier Séror, Olivier Sutter, Jean‐Charles Nault	1
2	Imaging and histological features of tumor biopsy sample predict aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation 2022 ·Scientific Reports ·Elia Gigante, (unknown), Jean‐Charles Nault, Olivier Sutter, Einas Abou Ali, (unknown), G. Nkontchou, Véronique Grando, Nathalie Ganne‐Carrié, Pierre Nahon, Lorraine Blaise, Julien Caldéraro, Nathalie Barget, Olivier Séror, Marianne Ziol	2
3	Circulating levels of CXCL11 and CXCL12 are biomarkers of cirrhosis in patients with chronic hepatitis C infection 2019 ·Cytokine ·(unknown), Benjamin Lefèvre, (unknown), Nathalie Barget, Laurence Amiot, Michel Samson	15
4	Influence of Progenitor‐Derived Regeneration Markers on Hepatitis C Virus–Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort) 2018 ·Hepatology ·Dominique Wendum, Richard Layese, Nathalie Ganne‐Carrié, Valérie Bourcier, Fatiha Merabtene, Carole Cagnot, (unknown), Nathalie Barget, Pierre Bédossa, Benoı̂t Terris, Janick Sèlves, Paulette Bioulac‐Sage, Nathalie Stürm, (unknown), Pierre Nahon, Françoise Roudot‐Thoraval, Marianne Ziol, (unknown)	7
5	Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib 2016 ·Molecular Cancer ·Aline Houessinon, (unknown), Chloé Sauzay, Christophe Louandre, Gaëlle Mongélard, Corinne Godin, Sandra Bodeau, Shinichiro Takahashi, Zuzana Saidak, Laurent Gutierrez, Jean‐Marc Régimbeau, Nathalie Barget, Jean‐Claude Barbare, Nathalie Ganne‐Carrié, Bruno Chauffert, Romain Coriat, Antoine Galmiche	116
6	ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma 2013 ·Journal of Hepatology ·Marianne Ziol, Angéla Sutton, Julien Caldéraro, Nathalie Barget, Mounir Aout, Vincent Leroy, Jean-Frédéric Blanc, Nathalie Stürm, Paulette Bioulac‐Sage, Pierre Nahon, Jean‐Charles Nault, Nathalie Charnaux, G. Nkontchou, Jean–Claude Trinchet, Maryse Delehedde, Olivier Séror, Michel Beaugrand, Éric Vicaut, Nathalie Ganne‐Carrié	34
7	Insulin-like growth factor 2 gene methylation in peripheral blood mononuclear cells of patients with hepatitis C related cirrhosis or hepatocellular carcinoma 2012 ·Clinics and Research in Hepatology and Gastroenterology ·Philippe Couvert, Alain Carrié, Sophie Tézenas du Montcel, J Vaysse, Angéla Sutton, Nathalie Barget, Jean–Claude Trinchet, Michel Beaugrand, Nathalie Ganne‐Carrié, Philippe Giral, Jamel Chelly	13
8	Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective study 2011 ·Clinics and Research in Hepatology and Gastroenterology ·Abdelhalim Mahmoudi, N. Sellier, Jeanne Reboul‐Marty, Gérard Chalès, Yoann Lalatonne, Valérie Bourcier, V. Grando, Nathalie Barget, Michel Beaugrand, J.C. Trinchet, Nathalie Ganne‐Carrié	16
9	A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma 2010 ·BMC Cancer ·Tim F. Greten, Alejandro Forner, Firouzeh Korangy, G. Nkontchou, Nathalie Barget, Carmen Ayuso, Lars A. Ormandy, Michael P. Manns, Michel Beaugrand, Jordi Bruix	174
10	215 A PHASE II OPEN LABEL TRIAL EVALUATING SAFETY AND EFFICACY OF A TELOMERASE PEPTIDE VACCINATION IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA 2010 ·Journal of Hepatology ·Tim F. Greten, Alejandro Forner, Firouzeh Korangy, G. Nkontchou, Nathalie Barget, Carmen Ayuso, Lars A. Ormandy, Michael P. Manns, Michel Beaugrand, Jordi Bruix	3
11	Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis 2009 ·European Journal of Gastroenterology & Hepatology ·Marianne Ziol, A. Kettaneh, Nathalie Ganne‐Carrié, Nathalie Barget, (unknown), Michel Beaugrand	32
12	Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case–control study 2009 ·European Journal of Gastroenterology & Hepatology ·Pierre Nahon, A. Kettaneh, Maud Lemoine, Olivier Séror, Nathalie Barget, Jean–Claude Trinchet, Michel Beaugrand, Nathalie Ganne‐Carrié	24
13	ABCB4 Heterozygous Gene Mutations Associated With Fibrosing Cholestatic Liver Disease in Adults 2008 ·Gastroenterology ·Marianne Ziol, Véronique Barbu, Olivier Rosmorduc, (unknown), Nathalie Barget, Brigitte Hermelin, (unknown), (unknown), Jean–Claude Trinchet, Michel Beaugrand, Nathalie Ganne‐Carrié	113
14	Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study 2007 ·European Journal of Gastroenterology & Hepatology ·Pierre Nahon, Angéla Sutton, Pierre Rufat, (unknown), Chantal Simon, Nathalie Barget, Jean–Claude Trinchet, Michel Beaugrand, Liliane Gattegno, Nathalie Charnaux	19
15	Liver Stiffness Measurement Versus Clinicians' Prediction or Both for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C 2006 ·The American Journal of Gastroenterology ·Pierre Nahon, Gabriel Thabut, Marianne Ziol, Myint Tin Tin Htar, (unknown), Nathalie Barget, Véronique Grando–Lemaire, Nathalie Ganne‐Carrié, Jean–Claude Trinchet, Michel Beaugrand	29
16	Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis 2006 ·British Journal of Cancer ·Douglas G. Ward, Ye Cheng, G. Nkontchou, (unknown), Nathalie Barget, Wenbin Wei, Lucinda Billingham, A Martin, Michel Beaugrand, Philip J. Johnson	51
17	Preclinical and post-treatment changes in the HCC-associated serum proteome 2006 ·British Journal of Cancer ·Douglas G. Ward, Ye Cheng, G. Nkontchou, (unknown), Nathalie Barget, Wenbin Wei, A Martin, Michel Beaugrand, Philip J. Johnson	21
18	Interferon gamma‐secreting HCV‐specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis – ANRS HC EP07 study* 2006 ·Journal of Viral Hepatitis ·Nelly Bonilla, Nathalie Barget, Muriel Andrieu, Dominique Roulot, P. Letoumelin, V. Grando, Jean–Claude Trinchet, Nathalie Ganne‐Carrié, Michel Beaugrand, Paul Dény, Jeannine Choppin, J G Guillet, Marianne Ziol	14
19	459 Correlation between liver elasticity measured by transient elastography and liver fibrosis assessed by morphometry in patients with HCV chronic hepatitis 2004 ·Journal of Hepatology ·Marianne Ziol, Nathalie Barget, Laurent Sandrin, Charles Fournier, F. Mal, Farhad Kazemi, A. Kettaneh, Michel Beaugrand	3
20	Delayed viral replication and CD4+ T cell depletion in the rectosigmoid mucosa of macaques during primary rectal SIV infection 2003 ·Virology ·Anne Couëdel-Courteille, Jean‐Luc Prétet, Nathalie Barget, Sébastien Jacques, Karine Petitprez, M Tulliez, Jean‐Gerard Guillet, Alain Venet, Cécile Butor	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact